pharmaceutical investing Pfizer Announces Overall Survival Results from Phase 3 PALOMA-3 Trial of IBRANCE in HR+, HER2- Metastatic Breast Cancer
pharmaceutical investing MacroGenics Provides Update on Corporate Progress and 2017 Financial Results
Merus Announces First Patient Dosed in a Phase 2 Clinical Trial of MCLA-128 in Two Metastatic Breast Cancer Patient Populations
pharmaceutical investing Cascadian Therapeutics Gets Pediatric Investigation Plan Waiver for Lead Candidate
Standard Uranium Increases Drill Program Size at Flagship Davidson River Project and Announces Non-Brokered Private Placement
SAGA Metals Reports Assays from R-0036 to R-0038 with Intercepts Including 50.46% Fe2O3, 7.21% TiO2, 0.395% V2O5 from 2026 Drilling at Trapper South, Radar Critical Minerals Project in Labrador
Laurion Commences Phase 1 Drilling At The Ishkoday Gold Project And Appoints Dr. Trevor Boyd, Ph.D., P.Geo. As Qualified Person
Armory Mining To Conduct Two Geophysical Surveys At The Ammo Gold-Antimony Project, Nova Scotia, Canada
